We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.24B
AUM Growth
+$127M
Cap. Flow
-$22.4M
Cap. Flow %
-1%
Top 10 Hldgs %
23.56%
Holding
2,404
New
91
Increased
577
Reduced
648
Closed
51

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.38M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.16M
3
XOM icon
ExxonMobil
XOM
+$2.1M
4
MSFT icon
Microsoft
MSFT
+$1.73M
5
TWTR
Twitter, Inc.
TWTR
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 13.98%
3 Financials 12.55%
4 Consumer Discretionary 8.54%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLVX
2126
DELISTED
HilleVax
HLVX
$15.2K ﹤0.01%
911
CCCC icon
2127
C4 Therapeutics
CCCC
$497M
$15.2K ﹤0.01%
2,583
LIND icon
2128
Lindblad Expeditions
LIND
$2.26B
$15.2K ﹤0.01%
1,970
FULC icon
2129
Fulcrum Therapeutics
FULC
$283M
$15.1K ﹤0.01%
2,078
ULH icon
2130
Universal Logistics Holdings
ULH
$524M
$15.1K ﹤0.01%
451
BCML icon
2131
BayCom
BCML
$341M
$15.1K ﹤0.01%
793
BIRD icon
2132
Smartbird Inc
BIRD
$31.2M
$14.9K ﹤0.01%
309
APEI icon
2133
American Public Education
APEI
$835M
$14.9K ﹤0.01%
+1,210
New +$15K
TRUE
2134
DELISTED
TrueCar
TRUE
$14.8K ﹤0.01%
+5,899
New +$12.3K
DMRC icon
2135
Digimarc Corp
DMRC
$162M
$14.8K ﹤0.01%
800
ALXO icon
2136
ALX Oncology
ALXO
$272M
$14.7K ﹤0.01%
1,308
EVLV icon
2137
Evolv Technologies
EVLV
$1.05B
$14.7K ﹤0.01%
5,691
WEBR
2138
DELISTED
Weber Inc.
WEBR
$14.7K ﹤0.01%
+1,827
New +$12.8K
CMAX
2139
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$14.7K ﹤0.01%
134
-1
-0.7% -$149
KRUS icon
2140
Kura Sushi USA
KRUS
$637M
$14.7K ﹤0.01%
308
HIPO icon
2141
Hippo Holdings
HIPO
$874M
$14.7K ﹤0.01%
1,078
NDLS icon
2142
Noodles & Co
NDLS
$102M
$14.7K ﹤0.01%
334
KOD icon
2143
Kodiak Sciences
KOD
$2.52B
$14.6K ﹤0.01%
2,042
HOV icon
2144
Hovnanian Enterprises
HOV
$799M
$14.6K ﹤0.01%
347
UVE icon
2145
Universal Insurance Holdings
UVE
$1.19B
$14.6K ﹤0.01%
1,378
NN icon
2146
NextNav
NN
$3.28B
$14.6K ﹤0.01%
4,973
RDVT icon
2147
Red Violet
RDVT
$1.18B
$14.5K ﹤0.01%
+631
New +$12.8K
NETI
2148
DELISTED
Eneti Inc.
NETI
$14.5K ﹤0.01%
1,442
HLTH
2149
DELISTED
Cue Health Inc. Common Stock
HLTH
$14.5K ﹤0.01%
6,983
NUVB icon
2150
Nuvation Bio
NUVB
$2.15B
$14.4K ﹤0.01%
7,525

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 Portfolio in Review

As of Q4 2022, Metropolitan Life Insurance Company (MetLife) held 2,404 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 filing shows 91 new, 577 increased, 648 reduced and 51 closed positions. Its largest new stake was Vanguard Total Bond Market: 419,639 shares worth $30.1M. The largest sale was Apple, an estimated $5.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2022 buy was Vanguard Total Bond Market: 419,639 shares worth $30.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $22.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2022 reduction was Apple, cutting an estimated $5.38M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.72M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $2.24B portfolio in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 91 new positions and closed 51 in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6% quarter-over-quarter to $2.24B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.